最新消息

News & Message

:::
2025/9/30

 Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors

  • Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors
    作者群:郭育筑(Yu-Chu Kuo), 鄭文建(Wen-Chien Cheng), 陳昫元(Hsu-Yuan Chen), 簡君儒(Chun-Ru Chien), 涂智彥(Chih-Yen Tu), 陳鴻仁(Hung-Jen Chen)
    期刊:Thoracic Cancer
    出版年月:2025 Sep.
    https://pubmed.ncbi.nlm.nih.gov/40963363/

相關文章

至頂